Understanding GA
GA Burden
- Impact of GA
- Patient Perspectives
Recognize and Refer
Resources
- For Optometrists
- For Patients

Sample OCT scan showing choroidal hypertransmission

Heading 1

Contact Us

|

Privacy Policy

|

Terms and Conditions

|

Sitemap

The APELLIS® name and logo is a registered trademark of Apellis Pharmaceuticals, Inc. Other trademarks referenced herein are the property of their respective owners. © 2023 Apellis Pharmaceuticals, Inc. 4/24 US-GA-2300090 v3.0

This site is intended for US eye care professionals only.

Year 4

BCVA: 20/25
Choroidal hypertransmission defect indicative of atrophy.

Thank you for signing up!

You should receive a welcome email in your inbox shortly.

You are now leaving RecognizeAndReferGA.com

This link will take you to another Apellis Pharmaceuticals, Inc. website.

Are you a US eye care professional?